← Leaderboards
Barbara E Stranger
University Of Chicago
$7,251,389
Attributed
$12,466,257
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2014–24$2.5M$1.9M$1.3M$625K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$12,466,257 · 7
By mechanism
R01$9,754,887 · 4
U01$1,830,331 · 1
UM1$674,849 · 1
R21$206,190 · 1
Top collaborators
- Rong Stephanie Huang8 shared
- Paul W. Burridge7 shared
- Lea K Davis4 shared
- Jochen Daniel Muehlschlegel4 shared
- Kevin P White2 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Alexander Jay Langerman$120,278
Others in their field
Top investigators on “Genomics”
- Eric S Lander · Whitehead Institute For Biomedical Res$790,826,794
- Richard A Gibbs · Baylor College Of Medicine$661,700,875
- Richard K. Wilson · Washington University$497,388,134
- Leonard Freedman · Leidos Biomedical Research, Inc.$405,398,682
- David Heimbrook · Leidos Biomedical Research, Inc.$333,649,126
- Stacey Gabriel · Massachusetts Institute Of Technology$331,896,891
Research focus
GenomicsGeneticGenesVariantPathway InteractionsSamplingGenetic VariantBiologicalGenome Wide Association StudyCohortBaseGene ExpressionResponseGenotypePharmaceutical PreparationsPredispositionMolecularTranscriptomeCellsTraitComplexLeadQuantitative Trait LociMediating
Grant awards (30)
Genomics of Post-Operative Atrial Fibrillation After Cardiac Surgery$746,205
R01 · FY2024 · HL
Elucidating the phenome-wide impact of sex and gender on disease$427,256
R01 · FY2024 · HG
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$418,795
R01 · FY2024 · CA · contact PI
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$137,615
R01 · FY2024 · CA · contact PI
Genomics of Post-Operative Atrial Fibrillation After Cardiac Surgery$764,593
R01 · FY2023 · HL
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$573,981
R01 · FY2023 · CA · contact PI
Elucidating the phenome-wide impact of sex and gender on disease$436,330
R01 · FY2023 · HG
Genomics of Post-Operative Atrial Fibrillation After Cardiac Surgery$742,415
R01 · FY2022 · HL
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$573,981
R01 · FY2022 · CA · contact PI
Elucidating the phenome-wide impact of sex and gender on disease$436,371
R01 · FY2022 · HG
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$332,271
R01 · FY2022 · CA
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$75,013
R01 · FY2022 · CA
Genomics of Post-Operative Atrial Fibrillation After Cardiac Surgery$812,780
R01 · FY2021 · HL
Elucidating the phenome-wide impact of sex and gender on disease$618,182
R01 · FY2021 · HG
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$339,052
R01 · FY2021 · CA
Assessing the ability of hiCMs to recapitulate patient-specific doxorubicin-induced cardiotoxicity$76,544
R01 · FY2021 · CA
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$1
R01 · FY2021 · CA · contact PI
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$582,549
R01 · FY2020 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$339,052
R01 · FY2020 · CA
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$622,374
R01 · FY2019 · CA · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$328,880
R01 · FY2019 · CA
Center for Functional Validation and Evaluation of ENCODE Enhancer Regions$174,849
UM1 · FY2019 · HG · contact PI
Genetic mechanisms underlying sexual dimorphism in cancer and response to therapy$31,595
R01 · FY2019 · CA · contact PI
Center for Functional Validation and Evaluation of ENCODE Enhancer Regions$500,000
UM1 · FY2018 · HG · contact PI
Genomic Prediction of Doxorubicin-Induced Cardiotoxicity$339,052
R01 · FY2018 · CA
Micro-western array methodology for assessment of preanalytical variability in bi$206,190
R21 · FY2016 · CA · contact PI
The genetic basis of cross-tissue protein expression variability in humans$100,000
U01 · FY2016 · HG · contact PI
The genetic basis of cross-tissue protein expression variability in humans$400,000
U01 · FY2015 · HG · contact PI
The genetic basis of cross-tissue protein expression variability in humans$1,092,415
U01 · FY2014 · HG · contact PI
The genetic basis of cross-tissue protein expression variability in humans$237,916
U01 · FY2014 · HG · contact PI